CIRCULATING CELL FREE TUMOR DNA MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Circulating Cell-Free Tumor DNA Market, by Tumor Type (Malignant Tumors, Precancerous Tumors), by Cancer Type (Lung Cancer, Colorectal Cancer, Breast Cancer, Others) by Technology (PCR, Massively Parallel Sequencing, Single Nucleotide Polymorphism), by Application (Cancer Diagnosis, Targeting Therapeutics, Prognosis Indication), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) -

Published In: 29 Apr, 2026
Code: CMI5819
Page number: 190
Formats: Excel and PDF
Industry: Biotechnology
- Historical Range : 2020 - 2024
- Base Year : 2025
- Estimated Year : 2026
- Forecast Period : 2026-2033

Table of Contents (Version-2026)

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Market Snapshot, By Tumor Type
  - Market Snapshot, By Cancer Type
  - Market Snapshot, By Technology
  - Market Snapshot, By Application
  - Market Snapshot, By Region
- Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
  - Drivers
  - Restraints
  - Market Opportunities
- Impact Analysis
- Key Highlights
- Product Launch
- Technological Advancements
- PEST Analysis
- Regulatory Scenario
- Mergers and Acquisitions
Global Circulating Cell-free Tumor DNA Market, By Tumor Type, 2021 – 2033, (US$ Billion)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 – 2033
  - Segment Trends
- Malignant Tumors
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Billion)
- Precancerous Tumors
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Billion)
Global Circulating Cell-free Tumor DNA Market, By Cancer Type, 2021 – 2033, (US$ Billion)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 – 2033
  - Segments Trends
- Lung Cancer
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Billion)
- Colorectal Cancer
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Billion)
- Breast Cancer
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Billion)
- Others
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Billion)
Global Circulating Cell-free Tumor DNA Market, By Technology, 2021 – 2033, (US$ Billion)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 – 2033
  - Segments Trends
- PCR
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Billion)
- Massively Parallel Sequencing
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Billion)
- Single Nucleotide Polymorphism
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Billion)
Global Circulating Cell-free Tumor DNA Market, By Application, 2021 – 2033, (US$ Billion)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 – 2033
  - Segment Trends
- Cancer Diagnosis
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Billion)
- Targeting Therapeutics
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Billion)
- Prognosis Indication
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Billion)
Global Circulating Cell-free Tumor DNA Market, By Region, 2021 – 2033, (US$ Billion)
- Introduction
  - Market Share Analysis, By Region, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, For Regions, 2022–2033
  - Regional Trends
- North America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Tumor Type, 2021 - 2033, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2021 - 2033, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (US$ Billion)
    - U.S.
    - Canada
- Latin America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Tumor Type, 2021 - 2033, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2021 - 2033, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (US$ Billion)
    - Brazil
    - Mexico
    - Argentina
    - Rest of Latin America
- Europe
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Tumor Type, 2021 - 2033, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2021 - 2033, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (US$ Billion)
    - U.K.
    - Germany
    - Italy
    - France
    - Spain
    - Russia
    - Rest of Europe
- Asia Pacific
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Tumor Type, 2021 - 2033, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2021 - 2033, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (US$ Billion)
    - China
    - India
    - Japan
    - ASEAN
    - Australia
    - South Korea
    - Rest of Asia Pacific
- Middle East
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Tumor Type, 2021 - 2033, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2021 - 2033, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (US$ Billion)
    - GCC
    - Israel
    - Rest of Middle East
- Africa
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Tumor Type, 2021 - 2033, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2021 - 2033, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 – 2033, (US$ Billion)
    - North Africa
    - Central Africa
    - South Africa
Competitive Landscape
- Biocept, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Illumina, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Quest Diagnostics Incorporated
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- KURABO INDUSTRIES LTD
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- PerkinElmer chemagen Technologie GmbH
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Biodesix
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Guardant Health
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- QIAGEN
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Sequenom, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Agilent Technologies, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Fluxion Biosciences Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Natera, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Agena Bioscience, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Paragon Genomics, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Lucence Health Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Eurofins Genomics
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Thermo Fisher Scientific
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
Section
- Research Methodology
- About Us

*Browse 35 market data tables and 34 figures on “Global Circulating Cell-free Tumor DNA Market” - Global forecast to 2033

Get Instant Access - Buy Now

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now

Credibility and Certifications

860519526

9001:2015

27001:2022

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

CIRCULATING CELL FREE TUMOR DNA MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Table of Contents (Version-2026)

Research Objectives and Assumptions

Market Purview

Market Dynamics, Regulations, and Trends Analysis

Global Circulating Cell-free Tumor DNA Market, By Tumor Type, 2021 – 2033, (US$ Billion)

Global Circulating Cell-free Tumor DNA Market, By Cancer Type, 2021 – 2033, (US$ Billion)

Global Circulating Cell-free Tumor DNA Market, By Technology, 2021 – 2033, (US$ Billion)

Global Circulating Cell-free Tumor DNA Market, By Application, 2021 – 2033, (US$ Billion)

Global Circulating Cell-free Tumor DNA Market, By Region, 2021 – 2033, (US$ Billion)

Competitive Landscape

Section

EXISTING CLIENTELE

U.S. Office:

Menu

Reader Club

Help

Connect With Us :

Secure Payment By :